NCT03462745 is a NA clinical trial of AccuVein AV 300 in Procedural Complication, sponsored by American University of Beirut Medical Center.

Who is sponsoring NCT03462745?

NCT03462745 is sponsored by American University of Beirut Medical Center.

What drugs are being tested in NCT03462745?

Interventions in NCT03462745: AccuVein AV 300.

What condition does NCT03462745 study?

NCT03462745 studies Procedural Complication.

Is NCT03462745 still recruiting?

NCT03462745 is currently completed. Last updated 26 February 2019.

Are results published for NCT03462745?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2019-02-26 · How we verify

NCT03462745

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Comparison of the First Attempt Success Rate of Cannulation Between the Accuvein Apparatus and Standard Technique

Completed NA Results posted Last updated 26 February 2019

What this trial tests

NA trial testing AccuVein AV 300 in Procedural Complication in 184 participants. Completed in 10 February 2014.

Timeline

10 February 2013

Primary endpoint
10 February 2014

10 February 2014

Quick facts

Lead sponsor	American University of Beirut Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	other
Enrollment	184
Start date	10 February 2013
Primary completion	10 February 2014
Estimated completion	10 February 2014

Drugs / interventions tested

AccuVein AV 300

Conditions studied

Procedural Complication — all drugs for Procedural Complication →

Sponsor

American University of Beirut Medical Center

Who can join

Under 18, any sex, with Procedural Complication. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

First Attempt Success Rates With the AccuVein 300 Device Versus Standard Method Primary · Beginning of venous Cannulation until end of Cannulation, average of 1 min

Group	Value	95% CI
Cannulation With AccuVein AV 300	92
Standard Insertion	92

Sponsor's own description

Background: The AccuVein AV300 device helps in venepuncture and intravenous (IV) cannulation. It uses infrared light that can be absorbed by the blood hemoglobin so that veins location is clearly viewed on the skin's surface. Objectives: To assess the effectiveness of the AV300 device over the standard technique in increasing the ﬁrst-time success rate (SR) for pediatric patients who needed IV cannulation. Methods: This was a prospective cross study of patients aged 0-18 years scheduled for surgery or examination under anesthesia but without having an existing IV access and after providing consent form. Patients were randomized into two groups; cannulation with AV300 or standard insertion performed by experienced pediatric anesthesiologists and residents under training.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Procedural Complication

Currently open trials in the same condition.

NCT07242560 — Epidural Catheter and Port-Related Infections in Pain Clinic Patients · active not recruiting

Other American University of Beirut Medical Center trials

Trials by the same sponsor.

NCT07387848 — Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients With Relapsed B Cell Lym · Phase 2 · not yet recruiting
NCT07111000 — Testing the Epley Maneuver for Treating Dizziness in the Emergency Department: A Randomized Study · NA · not yet recruiting
NCT07059624 — Femoral Arterial Cannulation in Pediatrics · NA · recruiting
NCT06777875 — COMT and OPRM1 Polymorphisms and Their Effect on Post-Operative Pain in Children · recruiting
NCT06815952 — Enhancing Difficult Laryngoscopy Prediction Through A Mixed Scoring System · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03462745 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by American University of Beirut Medical Center
Last refreshed: 26 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03462745.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing